• leader board size
Case Studies2020-11-19T22:10:23-08:00

Case Studies

Cronos Group Inc Reports Q2 2025 Financial Results

TORONTO – Cronos Group Inc., a Canadian cannabinoid company with an international outreach, reported its Q2 2025 financial results, showcasing a 21% year-over-year increase in net revenue, reaching $33.5 million. The growth was primarily driven ...

Cresco Labs Reports Q2 2025 Financial Results

CHICAGO – Cresco Labs Inc. released its Q2 2025 financial results, revealing a mix of operational stability, revenue headwinds, and a pivotal debt restructuring. The company reported revenues of $164 million, down 11% from $184 ...

The Tax Challenges Plaguing the Cannabis Industry

LOS ANGELES-- The year 2022 brought forth a significant shift in the financial landscape for the cannabis industry, as businesses grappled with a pressing tax conundrum. With the looming income tax filing season, cannabis taxpayers ...

Navigating California’s Cannabis Debt Crisis

LOS ANGELES-- As California's cannabis market grapples with a mounting debt crisis, the fate of the industry hangs in the balance, centering around a controversial piece of legislation known as Assembly Bill 766, also referred ...

Altria-Backed Cannabis Producer Cronos Explores Sale

TORONTO-Cronos Group Inc, (CRON.TO) the Canadian cannabis producer backed by Altria Group Inc, the cigarette maker, has confirmed that it is currently engaged in discussions with potential buyers to explore the possibility of a sale, ...

NBA Removes Cannabis from Prohibited Substances List

NEW YORK- In a significant development, league officials and the NBA Players Association have recently inked a comprehensive collective bargaining agreement that effectively removes cannabis from the league's list of prohibited substances. This landmark agreement ...

Subscribe To Our Newsletter

Go to Top